Trials / Completed
CompletedNCT03827161
Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients
GLANCE 2 - Glucosamine and Chondroitin (G&C) Effects Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Fred Hutchinson Cancer Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glucosamine | Given PO |
| OTHER | Placebo | Given PO |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2019-02-01
- Last updated
- 2019-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03827161. Inclusion in this directory is not an endorsement.